Stock listing
Frankfurt:L9S Gyre Therapeutics, Inc. Aktie
German listing (Frankfurt) of Gyre Therapeutics, Inc. · home listing NASDAQ:GYRE
Follow Gyre Therapeutics, Inc. into a list and get an email when it puts out news.
Share price · FWB:L9S
€5.40 EUR 0.00 (0.0%)
Close on Oct 20, 2026
- Day range
- €5.40 – €5.40 EUROct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:GYRE · Home | $6.17 USD | +0.08 (+1.3%) | 242,073 | $6.08 | $6.34 | $6.08 | $6.09 | Close on Oct 20, 2026 |
| Frankfurt:L9S | €5.40 EUR | 0.00 (0.0%) | — | €5.40 | €5.40 | €5.40 | €5.40 | Close on Oct 20, 2026 |
- Ticker
- Frankfurt:L9S
- Asset type
- Stock
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Sep 3, 2026
Gyre Therapeutics to Participate in Upcoming September Investor Conferences
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 26 slides
Latest news
Decks
Investor Presentation (September 2026)
Investor deck · 26 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 44 slides · Aug 26, 2026
Investor Presentation (June 2026)
Investor deck · 42 slides · Jun 2, 2026
Investor Presentation (May 2026)
Investor deck · 21 slides · May 14, 2026
Gyre Therapeutics, Inc. on 6ix
- News releases
- 12 in the last 12 months · 128 in all · newest Sep 3, 2026 · oldest 2019
- Decks
- 9 decks · latest September 2026
Where Gyre Therapeutics, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:GYRE · Home listing | NASDAQ | United States | USD |
| LS Exchange:A3EE5F | LS Exchange | Germany | EUR |
| Lang & Schwarz:A3EE5F | Lang & Schwarz | Germany | EUR |
| BOATS:GYRE | BOATS | United States | USD |
| Dusseldorf:L9S | Dusseldorf | Germany | EUR |
| Frankfurt:L9S · This page | Frankfurt | Germany | EUR |
| Stuttgart:L9S | Stuttgart | Germany | EUR |
| Tradegate:L9S | Tradegate | Germany | EUR |
| gettex:L9S | gettex | Germany | EUR |
Log in to ask 6ix AI your own questions about Gyre Therapeutics, Inc.